CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Veliparib and Lapatinib, given to participants with metastatic triple negative breast cancer that have undergone ...
Birmingham, Alabama, United States
This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...
Phase 2
Birmingham, Alabama, United States and 12 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Birmingham, Alabama, United States and 49 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Birmingham, Alabama, United States and 11 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Birmingham, Alabama, United States of America and 131 other locations
or metastatic (spread to other parts of the body); triple negative breast cancer; epithelial ovarian cancer...
Phase 2
Birmingham, Alabama, United States and 55 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib [AZD1775]) in second or third line setting in patients with Triple...
Phase 2
Birmingham, Alabama, United States and 140 other locations
in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estro ...
Phase 2
Birmingham, Alabama, United States and 11 other locations
besides treating your disease.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed w...
Phase 1
Birmingham, Alabama, United States and 22 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Birmingham, Alabama, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal